Complete regression of metastatic malignant melanoma endoscopically after nivolumab administration

Korean J Intern Med. 2021 Nov;36(6):1532-1533. doi: 10.3904/kjim.2020.613. Epub 2021 Feb 5.

Authors

Dae Gon Ryu¹, Cheol Woong Choi¹, Su Jin Kim¹, Dae Hwan Kang¹, Su Bum Park¹

Affiliation

¹ Department of Internal Medicine, Medical Research Institute, Pusan National University School of Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea.

No abstract available

MeSH terms

Humans
Melanoma* / drug therapy
Nivolumab / adverse effects
Skin Neoplasms* / drug therapy

Substances

Nivolumab